Institutional investors purchased a net $89.9 thousand shares of SPNC during the quarter ended March 2017 and now own 89.94% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPPENHEIMERFUNDS, INC. Bought 516.3 Thousand shares of Spectranetics Corp
REDMILE GROUP LLC Bought 369.6 Thousand shares of Spectranetics Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 245.7 Thousand shares of Spectranetics Corp